NEW YORK, Dec. 6, 2022 /PRNewswire/ -- The medical diagnostics market size is forecast to grow by USD 74.58 billion at a CAGR of 6.15% between 2022 and 2027. The growth of the market will be driven by the high prevalence of infectious diseases. Furthermore, the global adoption of advanced diagnostic solutions will foster the growth of the market.
The report extensively covers the medical diagnostics market segmentation by type (IVD and diagnostic imaging), end-user (hospitals and clinics, diagnostic centers, research laboratories and institutes, and others), and geography (North America, Asia, Europe, and the Rest of the World (ROW)). Request A Sample Report
Medical diagnostics market - Vendors
The growing competition in the market is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Some vendors are also adopting inorganic growth strategies such as M&As to remain competitive in the market.
- 3M Co.
- Agilent Technologies Inc.
- Becton Dickinson & Co.
- Bio-Rad Laboratories Inc.
- bioMerieux SA
- Charles River Laboratories
- Danaher Corp.
- DiaSorin SpA
- F. Hoffmann La Roche Ltd.
- General Electric Co.
- Hologic Inc.
- Medtronic Plc
- QIAGEN NV
- Quest Diagnostics Inc.
- Quidel Corp.
Product Insights and News
- 3M Co.: The company offers medical diagnostics such as 3M Hydrophilic Films, 3M Substrates and Films, and 3M Adhesive, and Spacer Tapes.
- Agilent Technologies Inc.: The company offers medical diagnostics such as HER2 IQFISH pharmDx, PD L1 IHC 22C3 pharmDx, and PD L1 IHC 28-8 pharmDx.
- Bio-Rad Laboratories Inc.: The company offers medical diagnostics such as Blood Group Serology Testing, Hb Variants and Genetic Disorders, and Infectious Disease Testing.
- bioMerieux SA: The company offers medical diagnostics such as Emag and biofire filmarray.
For detailed insights about product offerings and the growth strategies adopted by vendors, buy the report.
Medical diagnostics market - Geographical Landscape
Asia is estimated to contribute to 38% of the market growth by 2027. The growth of the regional market is driven by various factors such as rising healthcare expenditures, increased aging and chronic prevalent population, and growing trends toward POC, clinical chemistry and molecular diagnostic tools. Also, the growing prevalence of microsporidia infection in the geriatric population and the high preference toward technology-integrated medical diagnostics and POC devices are contributing to the growth of the medical diagnostics market in Asia.
Medical diagnostics market - Market Segmentation
The IVD segment is estimated to contribute significantly to the global market's growth during the forecast period. The segment is driven by the growing importance of molecular, clinical, and immunoassay diagnostic techniques. Also, the increasing need for improved real-time diagnostic tools for the early diagnosis of communicable and chronic diseases is contributing to the growth of the segment. - Download a sample report
- CAGR of the market during the forecast period.
- Detailed information on factors that will drive the growth of the market between 2023 and 2027
- Precise estimation of the medical diagnostics market size and its contribution to the parent market.
- Accurate predictions about upcoming trends and changes in consumer behavior.
- Growth of the industry across North America, Asia, Europe, and the Rest of the World (ROW).
- Thorough analysis of the market's competitive landscape and detailed information about vendors.
- Comprehensive analysis of factors that will challenge the growth of medical diagnostics market vendors.
Technavio's library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to Technavio Insights
Related Reports:
- The heart attack diagnostics market size is expected to increase by USD 5.34 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.51%. The rising prevalence of cardiac disorders is notably driving the heart attack diagnostics market growth, although factors such as pricing pressure among the vendors may impede the market growth.
- The in-vitro diagnostics market is projected to grow by USD 33.16 billion with a CAGR of 6.89% during the forecast period 2021 to 2026. The increasing geriatric population with chronic and infectious diseases is one of the key drivers supporting the in-vitro diagnostics market growth.
Medical Diagnostics Market Scope |
|
Report Coverage |
Details |
Page number |
171 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.15% |
Market growth 2023-2027 |
USD 74.58 billion |
Market structure |
Fragmented |
YoY growth 2022-2023 (%) |
5.69 |
Regional analysis |
North America, Asia, Europe, and Rest of World (ROW) |
Performing market contribution |
Asia at 38% |
Key countries |
US, China, Japan, Germany, and UK |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
3M Co., Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Charles River Laboratories, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., General Electric Co., Hologic Inc., Medtronic Plc, QIAGEN NV, Quest Diagnostics Inc., Quidel Corp., Siemens AG, Sysmex Corp., and Thermo Fisher Scientific Inc. |
Market dynamics |
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2022
- 3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
- 4.1 Global medical diagnostics market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on Global medical diagnostics market 2017 - 2021 ($ billion)
- 4.2 Type Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ billion)
- 4.3 End-user Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ billion)
- 4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ billion)
- 4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ billion)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type
- 6.1 Market segments
- Exhibit 30: Chart on Type - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
- 6.2 Comparison by Type
- Exhibit 32: Chart on Comparison by Type
- Exhibit 33: Data Table on Comparison by Type
- 6.3 IVD - Market size and forecast 2022-2027
- Exhibit 34: Chart on IVD - Market size and forecast 2022-2027 ($ billion)
- Exhibit 35: Data Table on IVD - Market size and forecast 2022-2027 ($ billion)
- Exhibit 36: Chart on IVD - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on IVD - Year-over-year growth 2022-2027 (%)
- 6.4 Diagnostic imaging - Market size and forecast 2022-2027
- Exhibit 38: Chart on Diagnostic imaging - Market size and forecast 2022-2027 ($ billion)
- Exhibit 39: Data Table on Diagnostic imaging - Market size and forecast 2022-2027 ($ billion)
- Exhibit 40: Chart on Diagnostic imaging - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Diagnostic imaging - Year-over-year growth 2022-2027 (%)
- 6.5 Market opportunity by Type
- Exhibit 42: Market opportunity by Type ($ billion)
7 Market Segmentation by End-user
- 7.1 Market segments
- Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
- Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)
- 7.2 Comparison by End-user
- Exhibit 45: Chart on Comparison by End-user
- Exhibit 46: Data Table on Comparison by End-user
- 7.3 Hospitals and clinics - Market size and forecast 2022-2027
- Exhibit 47: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ billion)
- Exhibit 48: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ billion)
- Exhibit 49: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
- Exhibit 50: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
- 7.4 Diagnostic centers - Market size and forecast 2022-2027
- Exhibit 51: Chart on Diagnostic centers - Market size and forecast 2022-2027 ($ billion)
- Exhibit 52: Data Table on Diagnostic centers - Market size and forecast 2022-2027 ($ billion)
- Exhibit 53: Chart on Diagnostic centers - Year-over-year growth 2022-2027 (%)
- Exhibit 54: Data Table on Diagnostic centers - Year-over-year growth 2022-2027 (%)
- 7.5 Research laboratories and institutes - Market size and forecast 2022-2027
- Exhibit 55: Chart on Research laboratories and institutes - Market size and forecast 2022-2027 ($ billion)
- Exhibit 56: Data Table on Research laboratories and institutes - Market size and forecast 2022-2027 ($ billion)
- Exhibit 57: Chart on Research laboratories and institutes - Year-over-year growth 2022-2027 (%)
- Exhibit 58: Data Table on Research laboratories and institutes - Year-over-year growth 2022-2027 (%)
- 7.6 Others - Market size and forecast 2022-2027
- Exhibit 59: Chart on Others - Market size and forecast 2022-2027 ($ billion)
- Exhibit 60: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
- Exhibit 61: Chart on Others - Year-over-year growth 2022-2027 (%)
- Exhibit 62: Data Table on Others - Year-over-year growth 2022-2027 (%)
- 7.7 Market opportunity by End-user
- Exhibit 63: Market opportunity by End-user ($ billion)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 65: Chart on Market share by geography 2022-2027 (%)
- Exhibit 66: Data Table on Market share by geography 2022-2027 (%)
- 9.2 Geographic comparison
- Exhibit 67: Chart on Geographic comparison
- Exhibit 68: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2022-2027
- Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ billion)
- Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
- Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
- 9.4 Asia - Market size and forecast 2022-2027
- Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
- Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
- Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
- 9.5 Europe - Market size and forecast 2022-2027
- Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
- Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
- Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
- Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
- Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- 9.7 US - Market size and forecast 2022-2027
- Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ billion)
- Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ billion)
- Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
- 9.8 China - Market size and forecast 2022-2027
- Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ billion)
- Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ billion)
- Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
- 9.9 Japan - Market size and forecast 2022-2027
- Exhibit 93: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
- Exhibit 94: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
- Exhibit 95: Chart on Japan - Year-over-year growth 2022-2027 (%)
- Exhibit 96: Data Table on Japan - Year-over-year growth 2022-2027 (%)
- 9.10 Germany - Market size and forecast 2022-2027
- Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
- Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
- Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
- 9.11 UK - Market size and forecast 2022-2027
- Exhibit 101: Chart on UK - Market size and forecast 2022-2027 ($ billion)
- Exhibit 102: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
- Exhibit 103: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 104: Data Table on UK - Year-over-year growth 2022-2027 (%)
- 9.12 Market opportunity by geography
- Exhibit 105: Market opportunity by geography ($ billion)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 106: Impact of drivers and challenges in 2022 and 2027
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 108: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 109: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 110: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 111: Matrix on vendor position and classification
- 12.3 3M Co.
- Exhibit 112: 3M Co. - Overview
- Exhibit 113: 3M Co. - Business segments
- Exhibit 114: 3M Co. - Key news
- Exhibit 115: 3M Co. - Key offerings
- Exhibit 116: 3M Co. - Segment focus
- 12.4 Abbott Laboratories
- Exhibit 117: Abbott Laboratories - Overview
- Exhibit 118: Abbott Laboratories - Business segments
- Exhibit 119: Abbott Laboratories - Key news
- Exhibit 120: Abbott Laboratories - Key offerings
- Exhibit 121: Abbott Laboratories - Segment focus
- 12.5 Agilent Technologies Inc.
- Exhibit 122: Agilent Technologies Inc. - Overview
- Exhibit 123: Agilent Technologies Inc. - Business segments
- Exhibit 124: Agilent Technologies Inc. - Key news
- Exhibit 125: Agilent Technologies Inc. - Key offerings
- Exhibit 126: Agilent Technologies Inc. - Segment focus
- 12.6 Bio Rad Laboratories Inc.
- Exhibit 127: Bio Rad Laboratories Inc. - Overview
- Exhibit 128: Bio Rad Laboratories Inc. - Business segments
- Exhibit 129: Bio Rad Laboratories Inc. - Key news
- Exhibit 130: Bio Rad Laboratories Inc. - Key offerings
- Exhibit 131: Bio Rad Laboratories Inc. - Segment focus
- 12.7 bioMerieux SA
- Exhibit 132: bioMerieux SA - Overview
- Exhibit 133: bioMerieux SA - Product / Service
- Exhibit 134: bioMerieux SA - Key offerings
- 12.8 Charles River Laboratories
- Exhibit 135: Charles River Laboratories - Overview
- Exhibit 136: Charles River Laboratories - Business segments
- Exhibit 137: Charles River Laboratories - Key news
- Exhibit 138: Charles River Laboratories - Key offerings
- Exhibit 139: Charles River Laboratories - Segment focus
- 12.9 Danaher Corp.
- Exhibit 140: Danaher Corp. - Overview
- Exhibit 141: Danaher Corp. - Business segments
- Exhibit 142: Danaher Corp. - Key news
- Exhibit 143: Danaher Corp. - Key offerings
- Exhibit 144: Danaher Corp. - Segment focus
- 12.10 DiaSorin SpA
- Exhibit 145: DiaSorin SpA - Overview
- Exhibit 146: DiaSorin SpA - Business segments
- Exhibit 147: DiaSorin SpA - Key news
- Exhibit 148: DiaSorin SpA - Key offerings
- Exhibit 149: DiaSorin SpA - Segment focus
- 12.11 F. Hoffmann La Roche Ltd.
- Exhibit 150: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 151: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 152: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 153: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 154: F. Hoffmann La Roche Ltd. - Segment focus
- 12.12 General Electric Co.
- Exhibit 155: General Electric Co. - Overview
- Exhibit 156: General Electric Co. - Business segments
- Exhibit 157: General Electric Co. - Key news
- Exhibit 158: General Electric Co. - Key offerings
- Exhibit 159: General Electric Co. - Segment focus
- 12.13 Hologic Inc.
- Exhibit 160: Hologic Inc. - Overview
- Exhibit 161: Hologic Inc. - Business segments
- Exhibit 162: Hologic Inc. - Key news
- Exhibit 163: Hologic Inc. - Key offerings
- Exhibit 164: Hologic Inc. - Segment focus
- 12.14 QIAGEN NV
- Exhibit 165: QIAGEN NV - Overview
- Exhibit 166: QIAGEN NV - Product / Service
- Exhibit 167: QIAGEN NV - Key news
- Exhibit 168: QIAGEN NV - Key offerings
- 12.15 Quest Diagnostics Inc.
- Exhibit 169: Quest Diagnostics Inc. - Overview
- Exhibit 170: Quest Diagnostics Inc. - Business segments
- Exhibit 171: Quest Diagnostics Inc. - Key offerings
- Exhibit 172: Quest Diagnostics Inc. - Segment focus
- 12.16 Siemens AG
- Exhibit 173: Siemens AG - Overview
- Exhibit 174: Siemens AG - Business segments
- Exhibit 175: Siemens AG - Key news
- Exhibit 176: Siemens AG - Key offerings
- Exhibit 177: Siemens AG - Segment focus
- 12.17 Thermo Fisher Scientific Inc.
- Exhibit 178: Thermo Fisher Scientific Inc. - Overview
- Exhibit 179: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 180: Thermo Fisher Scientific Inc. - Key news
- Exhibit 181: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 182: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 183: Inclusions checklist
- Exhibit 184: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 185: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 186: Research methodology
- Exhibit 187: Validation techniques employed for market sizing
- Exhibit 188: Information sources
- 13.5 List of abbreviations
- Exhibit 189: List of abbreviations
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article